Results 251 to 260 of about 9,044,537 (408)

Therapeutic Drug Monitoring in Special Circumstances in Inflammatory Bowel Disease. [PDF]

J Clin Med
Povlsen S, Patel K, Roblin X, Papamichael K, Honap S.   +4 more
europepmc   +1 more source

Impact of APOE ε4 Genotype Load on Cognitive Function and Lipid Metabolism in Patients With Cerebral Small Vessel Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Apolipoprotein ε4 (APOE ε4) is a potent genetic risk factor for Alzheimer's disease (AD). However, its role in cerebral small vessel disease (CSVD) remains unclear. Given the clinical and pathological similarities between CSVD and AD, this study aimed to investigate the associations of APOE ε4 gene dosage with cognitive function and
Tingru Jin, Haocheng Yang, Feng Liu, Sihao Lin, Junru Hu, Jian Wang, Yulan Gou   +6 more
wiley   +1 more source

Utility of therapeutic drug monitoring in the treatment of major depressive disorder. [PDF]

Curr Opin Psychiatry
Schoretsanitis G, Paulzen M.
europepmc   +1 more source

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.

Clinical Gastroenterology and Hepatology, 2019
K. Papamichael, A. Cheifetz, G. Melmed, P. Irving, N. V. Casteele, P. Kozuch, L. Raffals, L. Baidoo, B. Bressler, S. Devlin, Jennifer L Jones, G. Kaplan, M. Sparrow, F. Velayos, T. Ullman, C. Siegel   +15 more
semanticscholar   +1 more source

The MMP‐9/TIMP‐1 Ratio and Concentrations of Osteopontin Are Elevated in Cerebrospinal Fluid of People With Multiple Sclerosis and Decrease After Autologous Hematopoietic Stem Cell Transplantation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives To evaluate the utility of cerebrospinal fluid (CSF) biomarkers—matrix metalloproteinase‐9 (MMP‐9), tissue inhibitor of metalloproteinases‐1 (TIMP‐1), the MMP‐9/TIMP‐1 ratio, and osteopontin (OPN)—as indicators of blood–brain barrier (BBB) integrity and disease activity in people with relapsing–remitting multiple sclerosis (pwMS ...
Ivan Pavlovic, Ida Erngren, Kim Kultima, Anders Larsson, Malin Müller, Anna Wiberg, Joachim Burman   +6 more
wiley   +1 more source

Improved M.A.P. Bayesian Timeshared Computer Programs for Planning, Monitoring, and Adjusting Drug Dosage Regimens

, 1983
R W Jelliffe, Alan Schumitzky, David Z. D’Argenio, Darryl Katz, William F. Nicholson, James E. Rodman, Tony Hurst, T Gilman, T Kennedy   +8 more
openalex  

RFID-based Drug Management and Monitoring System, Case of Public Hospitals in Tanzania, A Review Paper

, 2015
Prisila Ishabakaki, Shubi Kaijage
openalex   +1 more source

Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study [PDF]

, 2018
Henit Yanai, Iris Dotan
openalex   +1 more source

Domain Specific Placebo Response in the Modified Friedreich's Ataxia Rating Scale

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The placebo response in clinical trials in ataxias complicates outcome interpretation and potentially obscures genuine treatment effects. We analyzed placebo group data from past trials in Friedreich Ataxia and observed notable responses in appendicular items, in contrast to minimal changes in axial function, as measured by respective ...
Christian Rummey, Jennifer M. Farmer, David R. Lynch   +2 more
wiley   +1 more source

Therapeutic Drug Monitoring of Thiopurine Therapy in Patients with Inflammatory Bowel Disease

, 2019
Poļina Zaļizko
openalex   +1 more source